Simcere Pharmaceutical (China)

535 papers and 5.2k indexed citations i.

About

In recent decades, authors affiliated with Simcere Pharmaceutical (China) have published 535 papers, which have received a total of 5.2k indexed citations. Scholars at this organization have produced 226 papers in Molecular Biology, 166 papers in Oncology and 128 papers in Pulmonary and Respiratory Medicine on the topics of Lung Cancer Treatments and Mutations (60 papers), Cancer Immunotherapy and Biomarkers (55 papers) and Cancer Genomics and Diagnostics (53 papers). Their work is cited by papers focused on Molecular Biology (2.5k citations), Oncology (1.1k citations) and Cancer Research (720 citations). Authors at Simcere Pharmaceutical (China) collaborate with scholars in China, United States and United Kingdom and have published in prestigious journals including Proceedings of the National Academy of Sciences, Nucleic Acids Research and Advanced Materials. Some of Simcere Pharmaceutical (China)'s most productive authors include Wen Wang, Xiaojin Yin, Feng Tang, Wei Huang, Minhang Xin, Dake Li, Aijun Lu, Jianping Zhou, Yin Ji and Mengjie Zheng.

In The Last Decade

Fields of papers published by authors at Simcere Pharmaceutical (China)

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Simcere Pharmaceutical (China) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Simcere Pharmaceutical (China) at the time of their publication.

Countries citing scholars working at Simcere Pharmaceutical (China)

Since Specialization

Citations

This map shows the geographic impact of research produced by authors working at Simcere Pharmaceutical (China). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Simcere Pharmaceutical (China) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simcere Pharmaceutical (China) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Foshan Hospital of TCM Breakdown of academic impact, for scholars at Deccan College of Medical Sciences Breakdown of academic impact, for scholars at Kliničko Bolnički Centar Zvezdara Breakdown of academic impact, for scholars at Beijing Building Construction Research Institute (China) Breakdown of academic impact, for scholars at Samsung (India) Breakdown of academic impact, for scholars at Fukushima Medical University Hospital Breakdown of academic impact, for scholars at Kagawa University Hospital Breakdown of academic impact, for scholars at Jiading District Central Hospital